In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with 89Zr-labeled avelumab.
Year: 2020
Type: article
Abstract: Zr-Df-Ave for non-invasive characterization of PD-L1 expression in BrCa and the applicability of this tracer in BrCa for treatment evaluation after immunotherapy.
Source: PubMed
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W3033203115
